Dr Antoine Hollebecque
- Specialty
- Oncologist, colon, stomach, liver and pancreas expert
- Hospital
- Gustave Roussy (Villejuif)
- Latest articles
-
- Final Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations. (Sep 30, 2025)
- Impact of oncology review meetings on second opinions for patients with gastrointestinal cancer. (Sep 20, 2025)
- Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study. (Sep 9, 2025)
- IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors. (Sep 1, 2025)
- Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma. (Aug 12, 2025)